Репозиторий OAI—PMH
Репозиторий Российская Офтальмология Онлайн по протоколу OAI-PMH
Конференции
Офтальмологические конференции и симпозиумы
Видео
Видео докладов
Реферат RUS | Реферат ENG | Литература | Полный текст |
УДК: | 617.7 DOI: https://doi.org/10.25276/2307-6658-2021-3-44-53 |
Бржеский В.В., Коникова О.А., Садовникова Н.Н., Ефимова Е.Л.
Изменения органа зрения у детей и взрослых на фоне COVID-19 и противоэпидемических мероприятий
1. Онуфрийчук О.Н., Газизова И.Р., Малюгин Б.Э., Куроедов А.В.Коронавирусная инфекция (COVID-19): офтальмологические проблемы. Обзор литературы. Офтальмохирургия. 2020;3: 70–79. [Onufrijchuk ON, Gazizova IR, Malyugin BE, Kuroedov AV. Koronavirusnaya infekciya (COVID-19): oftal'mologicheskie problemy. Obzor literatury. Oftal'mohirurgiya. 2020;3: 70–79. (In Russ.)]
2. Pardhan S, Vaughan M, Zhang J, et al.Sore eyes as the most significant ocular symptom experienced by people with COVID-19: a comparison between pre-COVID-19 and during COVID-19 states. BMJ Open Ophthalmology. 2020;5: e000632. doi: 10.1136/bmjophth-2020-000632
3. Sun X, Zhang X, Chen X, et al. The infection evidence of SARSCoV-2 in ocular surface: a single-center cross-sectional study. MedRxiv. 2020. doi: 10.1101/2020.02.26.20027938
4. Газизова И.Р., Дешева Ю.А., Гаврилова Т.В., Черешнев В.А. Распространенность конъюнктивитов у пациентов с новой коронавирусной инфекцией (COVID-19) и меры профилактики. РМЖ. Клиническая офтальмология. 2020;2: 92–96. [Gazizova IR, Desheva YuA, Gavrilova TV, Chereshnev VA. Rasprostranennost' kon”yunktivitov u pacientov s novoj koronavirusnoj infekciej (COVID-19) i mery profilaktiki. RMZh. Klinicheskaya oftal'mologiya. 2020;2: 92–96. (In Russ.)]
5. Lawrenson JG, Buckley RJ. COVID-19 and the eye. Ophthalmic Physiol Opt. 2020;40: 383–388.
6. Ulhaq ZS, Soraya GV. The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value of ocular tissue/fluid. Graefes Arch Clin Exp Ophthalmol. 2020;258: 1351–1352.
7. Chen L, Liu M, Zhang Z, et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Brit J Ophthalmol. 2020;104: 748–751. doi: 10.1136/ bjophthalmol-2020-316304
8. Inomata T, Kitazawa K, Kuno T, et al. Clinical and prodromal ocular symptoms in coronavirus disease: a systematic review and meta-analysis. Invest Ophthalmol Vis Sci. 2020;61(10): 29.
9. Xia J, Tong J, Liu M, et al. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020;92: 583–594.
10. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382: 1708–1720.
11. Chen L, Deng С, Chen X, et al. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study. Acta Ophthalmol. 2020;98(8): e951–e959. doi: 10.1111/aos.14472
12. Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020;28: 391–395.
13. Lecler A, Cotton F, Lersy F, et al. Ocular MRI findings in patients with severe COVID-19: A retrospective multicenter observational study. Radiology. 2021;299(2): E226–E229. doi: 10.1148/radiol.2021204394
14. Navel V, Chiambaretta F, Dutheil F. Haemorrhagic conjunctivitis with pseudomembranous related to SARSCoV-2. Amtr J Ophthalmol. 20206;19: 100735. doi: 10.1016/j. ajoc.2020.100735
15. Salducci M, La Torre G. COVID-19 emergency in the cruise's ship: a case report of conjunctivitis. Clin Ter. 2020;171: 189– 191.
16. Cheema M, Aghazadeh H, Nazarali S, et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can J Ophthalmol. 2020;55(4): е125–е129. doi: 10.1016/j.jcjo.2020.03.003
17. Hong N, Yu W, Xia J, et al. Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19. Acta Ophthalmol. 2020;98: e649–e655. doi: 10.1111/ aos.14445
18. Daruich A, Martin D, Bremond-Gignac D. Unilateral conjunctivitis as first presentation of coronavirus disease 2019 (COVID-19): a telemedicine diagnosis. J Fr Ophtalmol. 2020;43: 167–168.
19. Willcox MDP, Walsh K, Nichols JJ, et al. The ocular surface, coronaviruses and COVID-19. Clin Exp Optom. 2020;103(4): 418–424. doi: 10.1111/cxo.13088
20. DiSciullo A, Mokhtari N, Fries M. Review of maternal COVID-19 infection: considerations for the pediatric ophthalmologist. J AAPOS. 2020;24: 209–211.
21. Olson DJ, Ghosh A, Zhang AY. Ophthalmic manifestations of coronavirus disease 2019 and ocular side effects of investigational pharmacologic agents. Curr Opin Ophthalmol. 2020;31: 403–415.
22. Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicenter of the SARSCoV-2 epidemic: an observational cohort study. Lancet. 2020;395: 1771–1778.
23. Pouletty M, Borocco C, Ouldali N, et al. Paediatric multisystem inflammatory syndrome temporally associated with SARSCoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort. Ann Rheum Dis. 2020;79: 999–1006.
24. Ma N, Li P, Wang X, et al. Ocular manifestations and clinical characteristics of children with laboratory-confirmed COVID-19 in Wuhan, China. JAMA Ophthalmol. 2020;138(10): 1079–1086. doi: 10.1001/jamaophthalmol.2020.3690
25. Ballouz D, Mian SI. Eye banking in the coronavirus disease 2019 era. Curr Opin Ophthalmol. 2020;31: 389–395.
26. Thuret G, Courrier E, Poinard S, et al. One threat, different answers: the impact of COVID-19 pandemic on cornea donation and donor selection across Europe. Brit J Ophthalmol. 2020;bjophthalmol-2020-317938: 1–7. doi: 10.1136/bjophthalmol-2020-317938
27. Baughman BD, Hansemann BK, Shah MM, Weizer JS. Drivethrough intraocular pressure checks during the COVID-19 pandemic. Glaucoma. 2021;30(3): 223–226.
28. Jain N, Kaur S, Kopsachilis N, Zia R.Risk of airborne COVID-19 transmission while performing Humphrey visual field testing. Glaucoma. 2021;30(3): 219–222.
29. Salica JP, Potilinski C, Querci M, et al. Ophthalmic surgery during the COVID-19 pandemic, from start to finish. Clinical Ophthalmology. 2021;15: 261–278.
30. Onga SC, Yapb JX, Tay TYF, et al. Considerations in the use of slit lamp shields to reduce the risk of respiratory virus transmission in coronavirus disease 2019. Curr Opin Ophthalmol. 2020;31: 374–379.
31. Kalavara M, Huab H-U, Sridhara J. Teleophthalmology: an essential tool in the era of the novel coronavirus 2019. Curr Opin Ophthalmol. 2020;31: 366–373.
32. Boccardo L. Self-reported symptoms of mask-associated dry eye: A survey study of 3,605 people. Cont Lens Anter Eye. 2021;101408. doi: 10.1016/j.clae.2021.01.003
33. Бржеский В.В., Проскурина О.В., Иомдина Е.Н. и др. Компьютерный зрительный синдром: четверть века противоречий. М.: ООО «Сентисс Рус». 2020: 70. [Brzheskij VV, Proskurina OV, Iomdina EN, i dr. Komp'yuternyj zritel'nyj sindrom: chetvert' veka protivorechij. M.: OOO «Sentiss Rus». 2020: 70. (In Russ.)]
34. Martin GC, Le Roux G, Guindolet D, et al. Pediatric eye injuries by hydroalcoholic gel in the context of the Coronavirus Disease 2019 pandemic. JAMA Ophthalmol. 2021;139(3): 348–351. doi: 10.1001/jamaophthalmol.2020.6346
35. Wang J, Li Y, Musch DC. Progression of myopia in school-aged children after COVID-19 home confinement. JAMA Ophthalmol. 2021;139(3): 293–300. doi: 10.1001/ jamaophthalmol.2020.6239
Страница источника: 44-53
Каталог
Продукции
Организации
Офтальмологические клиники, производители и поставщики оборудования
Издания
Периодические издания
Партнеры
Проекта Российская Офтальмология Онлайн